# Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)

> **NCT00736463** · PHASE4 · UNKNOWN · sponsor: **Oregon Health and Science University** · enrollment: 80 (estimated)

## Conditions studied

- HDL Cholesterol

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Atorvastatin 80 mg

## Key facts

- **NCT ID:** NCT00736463
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-07-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736463, "Crossover of Higher Dose Statins in Patients With Low High-density Lipoproteins Cholesterol (HDLc)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00736463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*